LEANNE MUNIZ: Open Payments
NPI 1326510389 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$864 in 37 payments from 7 companies in 2025. Trend: 2023 $1,875 · 2024 $1,261 · 2025 $864
Food & beverage: $864
| Company | Payments | Amount |
|---|---|---|
| ViiV Healthcare Company | 15 | $390 |
| Gilead Sciences, Inc. | 14 | $294 |
| Merck Sharp & Dohme LLC | 2 | $47 |
| ABBVIE INC. | 2 | $39 |
| GlaxoSmithKline, LLC. | 1 | $35 |
| Napo Pharmaceuticals Inc | 2 | $33 |
| Hologic Sales and Service, LLC | 1 | $26 |
Products named: CABENUVA, DOVATO, APRETUDE, PIFELTRO, MAVYRET, Mytesi, Descovy, THINPREP 2000 PROCESSOR.
Industry payments across AZ — which companies pay providers there.
